TherapeuticsMD, Inc. (NASDAQ:TXMD) Sees Large Decrease in Short Interest

Posted by Micah Haroldson on Jan 16th, 2025

TherapeuticsMD, Inc. (NASDAQ:TXMD – Get Free Report) saw a significant decrease in short interest in December. As of December 31st, there was short interest totalling 12,000 shares, a decrease of 43.7% from the December 15th total of 21,300 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 275,000 shares, the days-to-cover ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on TherapeuticsMD in a research report on Tuesday. They issued a “hold” rating for the company.

View Our Latest Report on TherapeuticsMD

TherapeuticsMD Price Performance

NASDAQ TXMD traded up $0.11 on Wednesday, hitting $1.11. The company had a trading volume of 92,440 shares, compared to its average volume of 1,818,736. The company’s fifty day moving average price is $1.26 and its 200-day moving average price is $1.54. TherapeuticsMD has a 12-month low of $0.70 and a 12-month high of $2.75.

Institutional Trading of TherapeuticsMD

A hedge fund recently raised its stake in TherapeuticsMD stock. Clearline Capital LP raised its position in TherapeuticsMD, Inc. (NASDAQ:TXMD – Free Report) by 18.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 636,622 shares of the company’s stock after buying an additional 101,282 shares during the period. Clearline Capital LP owned about 5.52% of TherapeuticsMD worth $1,025,000 at the end of the most recent reporting period. 30.74% of the stock is currently owned by institutional investors.

About TherapeuticsMD

(Get Free Report)

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.